Request Appointment
161 Fort Washington AvenueNew York, NY 10032
Overview of Dr. Lee
Dr. Eun-Ju Lee is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 16 years. She is one of 402 doctors at New York-Presbyterian Hospital and one of 127 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 90 publications and over 500 citings.
Education & Training
University of Rochester Medical CenterResidency, Gastroenterology, 2021 - 2027
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
NY State Medical License 2012 - 2027
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Publications & Presentations
PubMed
- 6 citationsStrategies to overcome chemoresistance in epithelial ovarian cancer: Navigating beyond challenges.Que Thanh Thanh Nguyen, Jihye Kim, Hee Chan Yoo, Eun-Ju Lee
Critical Reviews in Oncology/hematology. 2025-06-01 - Perspectives on Intravenous Iron Therapy Logistics and Adherence: Results from a Patient Survey.Eun-Ju Lee, Les Louden, Janelle Applequist, Barbara J Wilson, Joshua Strauss
Patient Related Outcome Measures. 2025-01-01 - 9 citationsCustomized small-sized clinostat using 3D printing and gas-permeable polydimethylsiloxane culture dish.Daehan Kim, Que Thanh Thanh Nguyen, Seungjin Lee, Kyung-Mi Choi, Eun-Ju Lee
NPJ Microgravity. 2023-08-11
Journal Articles
- Dickkopf-3 in Human Malignant Tumours: A Clinical ViewpointEun-Ju Lee, MD, Anticancer Research
Press Mentions
Dramatic Increase in Response with Combination for Relapsed/Resistant ITPJanuary 28th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:






